241 related articles for article (PubMed ID: 15906273)
1. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?
Korsching E; Packeisen J; Liedtke C; Hungermann D; Wülfing P; van Diest PJ; Brandt B; Boecker W; Buerger H
J Pathol; 2005 Aug; 206(4):451-7. PubMed ID: 15906273
[TBL] [Abstract][Full Text] [Related]
2. Re: Korsching et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 2005; 206: 451-457.
Reis-Filho JS
J Pathol; 2005 Nov; 207(3):367-9; author reply 370-1. PubMed ID: 16155968
[No Abstract] [Full Text] [Related]
3. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
4. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer.
Hungermann D; Schmidt H; Natrajan R; Tidow N; Poos K; Reis-Filho JS; Brandt B; Buerger H; Korsching E
J Pathol; 2011 Aug; 224(4):517-28. PubMed ID: 21706489
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
Rohilla M; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
[TBL] [Abstract][Full Text] [Related]
7. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
8. Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue.
Simpson PT; Gale T; Reis-Filho JS; Jones C; Parry S; Steele D; Cossu A; Budroni M; Palmieri G; Lakhani SR
J Pathol; 2004 Mar; 202(3):274-85. PubMed ID: 14991892
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
[TBL] [Abstract][Full Text] [Related]
10. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation.
Tsuda H; Morita D; Kimura M; Shinto E; Ohtsuka Y; Matsubara O; Inazawa J; Tamaki K; Mochizuki H; Tamai S; Hiraide H
Cancer Sci; 2005 Jan; 96(1):48-53. PubMed ID: 15649255
[TBL] [Abstract][Full Text] [Related]
11. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
Reis-Filho JS; Steele D; Di Palma S; Jones RL; Savage K; James M; Milanezi F; Schmitt FC; Ashworth A
Mod Pathol; 2006 Feb; 19(2):307-19. PubMed ID: 16424897
[TBL] [Abstract][Full Text] [Related]
12. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas.
Malzahn K; Mitze M; Thoenes M; Moll R
Virchows Arch; 1998 Aug; 433(2):119-29. PubMed ID: 9737789
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
14. Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.
Celis JE; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans-Wielenga V; Rank F; Moreira JM
Mol Oncol; 2007 Dec; 1(3):321-49. PubMed ID: 19383306
[TBL] [Abstract][Full Text] [Related]
15. The relationship between p63 and p53 expression in normal and neoplastic breast tissue.
Ribeiro-Silva A; Zambelli Ramalho LN; Britto Garcia S; Zucoloto S
Arch Pathol Lab Med; 2003 Mar; 127(3):336-40. PubMed ID: 12653579
[TBL] [Abstract][Full Text] [Related]
16. Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma.
Kesse-Adu R; Shousha S
Mod Pathol; 2004 Jun; 17(6):646-52. PubMed ID: 15073596
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of alpha-smooth muscle actin in infiltrating ductal carcinoma of the breast with productive fibrosis.
Tamiolakis D; Papadopoulos N; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Simopoulos C
Eur J Gynaecol Oncol; 2002; 23(5):469-71. PubMed ID: 12440829
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of ductal cells with putative myoepithelial markers: A potential pitfall in breast carcinoma.
Nayar R; Breland C; Bedrossian U; Masood S; DeFrias D; Bedrossian CW
Ann Diagn Pathol; 1999 Jun; 3(3):165-73. PubMed ID: 10359852
[TBL] [Abstract][Full Text] [Related]
19. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers.
Zhang RR; Man YG; Vang R; Saenger JS; Barner R; Wheeler DT; Liang CY; Vinh TN; Bratthauer GL
Breast Cancer Res; 2003; 5(5):R151-6. PubMed ID: 12927046
[TBL] [Abstract][Full Text] [Related]
20. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]